• Users Online: 175
  • Print this page
  • Email this page

 Table of Contents  
Year : 2022  |  Volume : 9  |  Issue : 1  |  Page : 39

Commentary on the article “Nanotechnology in spinal cord injury”

The Honourable Vice Chancellor, Mahatma Gandhi University, Kottayam, Kerala, India

Date of Submission22-Dec-2021
Date of Acceptance23-Dec-2021
Date of Web Publication9-Mar-2022

Correspondence Address:
Sabu Thomas
The Honourable Vice Chancellor, Mahatma Gandhi University, Kottayam, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/joss.joss_38_21

Rights and Permissions

How to cite this article:
Thomas S. Commentary on the article “Nanotechnology in spinal cord injury”. J Spinal Surg 2022;9:39

How to cite this URL:
Thomas S. Commentary on the article “Nanotechnology in spinal cord injury”. J Spinal Surg [serial online] 2022 [cited 2022 May 27];9:39. Available from: http://www.jossworld.org/text.asp?2022/9/1/39/339274

The use of nanoscience and nanotechnology in tissue engineering offers promising future possibilities for spinal cord injury (SCI) treatment. Stem cells could be used very selectively to target injured spinal cord tissues to improve functional recovery. Nanotechnologists across the globe are working extremely hard in developing new treatment protocols using nanotechnology platforms which include new prostheses and medications. This will promote nerve cell regeneration or improve the functions of the nerves that remain after a SCI.

The review by Dr. Vinu V. Gopal and Dr. Mahadevan[1] is an excellent contribution unraveling the possibilities of nanoscience and nanotechnology platforms for SCI and repair. A variety of in vivo animal testing for SCI has been used with or without cells, and some of these in vivo studies have shown successful results. However, there is no real translation to humans using nanotechnology for SCI treatment. Therefore, there is every need for joint effort by clinicians, surgeons, and nanotech academics to develop translation research in the area of SCI. Some of the recent research data indicate the safety and efficacy of stem cell therapy for SCI. The authors very carefully addressed these issues too. Finally, the authors demonstrated the use of robotics to treat SCI.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Gopal VV, Mahadevan K, Nanotechnology in Spinal Cord Injury: A New Hope for Overcoming Barriers to Treatment. J Spinal Surg 2015;2:74-8.  Back to cited text no. 1


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal